Insiders Cogent Biosciences, Inc.

Equities

COGT

US19240Q2012

Real-time Estimate Cboe BZX Other stock markets 15:41:03 08/05/2024 BST			5-day change	1st Jan Change
7.66 ^USD	-1.29%		+11.54%	+31.46%

05-07	Cogent Biosciences Q1 Loss Widens	MT
05-07	Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cogent Biosciences, Inc. Appoints Rachael Easton, VP, Head of Clinical Development	28/11/22	CI
Cogent Biosciences Appoints Evan Kearns as Chief Legal Officer	03/05/21	CI
Insider Trends: Cogent Biosciences Insider Extends 90-Day Selling Trend	29/04/21	MT
Cogent Biosciences Announces Creation of Cogent Research Team	06/04/21	CI
Cogent Biosciences, Inc. Appoints John Robinson as Chief Scientific Officer	06/04/21	CI
Cogent Biosciences, Inc. Appoints Sara Saltzman as Senior Vice President of Regulatory Affairs	16/03/21	CI
Cogent Biosciences Appoints Todd E. Shegog to its Board of Directors	22/02/21	CI
Cogent Biosciences, Inc. Appoints Brad Barnett as Chief Technology Officer	30/11/20	CI
Cogent Biosciences, Inc. Announces Executive Changes	26/10/20	CI
Cogent Biosciences, Inc Announces Executive Changes	26/10/20	CI
Cogent Biosciences, Inc Announces Management Changes	26/10/20	CI
Unum Therapeutics Inc. will Change its Name to Cogent Biosciences, Inc	06/10/20	CI
Unum Therapeutics Inc. Announces Changes to the Board and Appointments to the Committees	06/07/20	CI
Unum Therapeutics Inc. Announces Executive Changes	15/05/20	CI
Unum Therapeutics Inc. Plans to Reduce its Current Workforce; Announces Resignation of Seth Ettenberg as Chief Scientific Officer	02/03/20	CI
Unum Therapeutics Inc. Announces New Appointments to its Board of Directors	29/07/19	CI
Unum Therapeutics Inc. Announces Management Changes	25/07/19	CI
Unum Therapeutics Inc. Announces Management Changes	13/06/19	CI
Unum Therapeutics Inc. Appoints Christiana Stamoulis to the Additional Role of President	02/03/18	CI
Unum Therapeutics Inc. Appoints Karen J. Ferrante and Robert J. Perez to its Board of Directors	02/03/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cogent Biosciences, Inc.

Equities

COGT

US19240Q2012

Insiders

Filters